Form 8-K - Current report:
SEC Accession No. 0001213900-25-035636
Filing Date
2025-04-25
Accepted
2025-04-25 17:00:07
Documents
13
Period of Report
2025-04-23
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0239610-8k_incannex.htm   iXBRL 8-K 32550
  Complete submission text file 0001213900-25-035636.txt   209725

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ixhl-20250423.xsd EX-101.SCH 3014
3 XBRL LABEL FILE ixhl-20250423_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE ixhl-20250423_pre.xml EX-101.PRE 22358
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0239610-8k_incannex_htm.xml XML 3787
Mailing Address 8 CENTURY CIRCUIT STE. 105 NORWEST NSW C3 2153
Business Address 8 CENTURY CIRCUIT STE. 105 NORWEST NSW C3 2153 61 409 840 786
Incannex Healthcare Inc. (Filer) CIK: 0001873875 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41106 | Film No.: 25875031
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)